Camelyn

Camelyn LTD" is a privately owned Georgian Scientific-Pharmaceutical Company, founded by Ms. Ketevan Maglakelidze, Ms. Mzia Maglakelidze and Ms. Eliso Khadagishvili in 2004. The active ingredient "Camelyn M" was discovered and developed by Benedict (Dzaguli) Maglakelidze, who initiated studies on "Camelyn M" since 1950 and successfully led the research until 1974. Since then, the preparation "Camelyn M" has shown promising immunomodulatory results against the antibiotic-resistant bacteria, seasonal viruses and fungal complications. The company is dedicated towards producing immunomodulatory, antibacterial and antiviral treatment products, as well as identifying and developing biologically active compounds for the use in cosmetics and food supplement industry. The company is manufacturing biologically active natural compounds for use in medicine, food industry and cosmetics. Our company identifies Research and Development as one of the most critical areas leading to our company's success. Apart from employing well qualified technical staff, the company is in collaboration with a number of universities and research centres not only in Georgia but also in the United States of America, Canada and Europe. This allows "Camelyn" to stay on top of the new developments and assist in discovery of new therapeutic areas for infectious diseases. Our company is dedicated to keep on developing products that will enhance body's natural defence mechanisms, improve quality of life and save lives via immunomodulation.